Introduction
There is growing interest in non-surgical injections for joint wear, particularly in the knee. Two options that patients and clinicians increasingly compare are the ChondroFiller injection and hyaluronic acid. Both are outpatient, non-surgical procedures, but they work by different mechanisms and suit different goals. This article sets out a realistic comparison to help patients understand what each offers.
How They Work
Hyaluronic acid is a naturally occurring substance in joint fluid. It acts as a lubricant and shock absorber. When joint fluid loses its normal viscosity — as often happens in osteoarthritis — injecting hyaluronic acid can temporarily restore some of that lubrication and ease symptoms.
ChondroFiller takes a different approach. It is a CE-marked Class III medical device: an acellular, injectable type I collagen hydrogel scaffold manufactured by Meidrix Biomedicals in Germany and imported into the UK under prescription. When delivered as an ultrasound-guided outpatient injection, it may settle over worn cartilage surfaces, providing a protective collagen layer that helps cushion the joint and reduce grinding. The scaffold is acellular — it contains no added cells — and is designed to recruit the patient's own progenitor cells from the surrounding tissue to support cartilage repair. ChondroFiller is a regenerative injection, not a cure or a reversal of arthritis; benefits vary.
Comparing Goals
Hyaluronic acid mainly provides short-to-medium-term symptom relief and does not alter the underlying joint wear. It is a well-established option for symptom management, particularly in patients with mild-to-moderate osteoarthritis who have not responded fully to conservative measures.
ChondroFiller aims to support the joint surface itself by providing a collagen scaffold environment rather than simply lubricating it. A 2023 study of acellular collagen matrix injection for thumb-base osteoarthritis reported improvements in pain and grip strength (Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., and Lavagnolo, U., 2023, The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis, Cartilage), though individual responses vary. Both injections have distinct strengths and limitations; neither is suitable for all patients.
Patient Experience
Both options are non-surgical outpatient procedures. Hyaluronic acid is typically given as a series of injections over several weeks, each with a quick recovery. ChondroFiller involves an individual assessment including imaging to confirm suitability, followed by a single ultrasound-guided injection. Recovery is straightforward in both cases, with no theatre or general anaesthetic involved.
Because ChondroFiller is a Class III device delivered under prescription, a thorough specialist assessment is required before treatment. Suitability depends on joint condition, cartilage defect size, and overall clinical picture.
Choosing an Approach
The most appropriate option depends on what you are trying to achieve. If the primary goal is symptom relief and lubrication, hyaluronic acid is a proven choice. If the aim is to support the joint surface with a collagen scaffold that may promote a biological repair response, ChondroFiller injection may be worth considering — provided the assessment confirms suitability. The two injections are sometimes used at different stages or as part of a broader management plan.
No injection treatment guarantees recovery. Individual factors — age, activity level, the degree and pattern of joint wear, and overall health — all influence outcomes. Professional evaluation is essential before deciding on any course of treatment.
Conclusion
ChondroFiller and hyaluronic acid injections are two distinct non-surgical options that serve different biological purposes: hyaluronic acid primarily for lubrication and symptom relief, ChondroFiller as a collagen scaffold injection that aims to support the joint surface. Understanding the difference helps patients and clinicians choose the approach best matched to individual goals and joint condition. For individual advice, a specialist assessment is the appropriate first step.
References
Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., and Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.
Frequently Asked Questions
- Hyaluronic acid mainly lubricates the joint and provides short-to-medium-term symptom relief by restoring some of the viscosity of joint fluid. ChondroFiller is a CE-marked Class III collagen scaffold device that, when injected under ultrasound guidance, may settle over worn cartilage and provide a protective, cushioning layer. Neither is a cure for arthritis.
- No. ChondroFiller is the CE-marked collagen scaffold device. The ChondroFiller injection is the non-surgical, ultrasound-guided outpatient delivery of that scaffold. Liquid Cartilage is a separate, surgical procedure — Professor Paul Lee's keyhole (arthroscopic) protocol that places ChondroFiller alongside biological adjuncts and, where indicated, the patient's own stem cells, performed under anaesthetic in theatre. This article is about the non-surgical ChondroFiller injection, not the Liquid Cartilage surgical procedure.
- People who want a collagen-based option that aims to support the joint surface rather than primarily lubricate it, and who have confirmed suitability on specialist assessment. ChondroFiller is a prescription Class III device, so individual evaluation — including imaging — is required before proceeding.
- Hyaluronic acid is most commonly used in the knee but is also used in other joints. ChondroFiller has been studied in the knee, hip, thumb base, and other joints. Suitability for any joint depends on the nature and extent of cartilage wear and individual clinical factors.
- Because the right option depends on the type and severity of joint wear, the specific joint affected, your activity level, and your goals. Benefits vary between patients, and a specialist can review imaging and clinical findings to advise which approach — or combination — makes most sense for your situation.
Where to go from here
A few next steps tailored to what you have just read.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].
